Clik here to view.
Zimmer Biomet closes $1B senior debt offering
Zimmer Biomet (NYSE:ZBH) said today it closed its an offering of Euro-dominated senior notes, bringing in over $1 billion. The company brought in $530 million (EU €500 million) in principal amount of...
View ArticleClik here to view.
Bioventus picks up US Durolane rights from Galderma
Bioventus said today it inked a deal to pick up the U.S. rights for Durolane joint lubrication from Galderma for an undisclosed amount. Galderma’s Durolane is a single-injection, hyaluornic acid...
View ArticleClik here to view.
AARP report details increase in brand name drug prices
The AARP Public Policy Institute released a report today showing that 2015 was the 4th straight year of double-digit average annual increases for widely used brand name drugs. The nonprofit...
View ArticleClik here to view.
BioDelivery names Ginsberg as biz dev veep | Personnel Moves, Dec. 14, 2016
BioDelivery Sciences International (NSDQ:BDSI) said today that it named Peter Ginsberg as its VP of business development. Prior to joining the Raleigh, N.C.-based company, Ginsberg led business...
View ArticleClik here to view.
Zimmer-Biomet launches PrimaGen advanced bone allograft
Zimmer Biomet (NYSE:ZBH) said today it launched the PrimaGen advanced bone allograft designed as an allogeneic bone graft substitute for use in the repair, replacement, reconstruction or...
View ArticleClik here to view.
Researchers develop nanorockets that respond to changing temperatures
Researchers at Radboud University have developed nanorockets with temperature responsive “brakes”, enabling the carrier to stop in diseased tissues where temperatures are higher. The team’s work was...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for December 14, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Clarius wins FDA 510(k) for wireless ultrasound device
Mobile ultrasound developer Clarius Mobile Health said today it won FDA 510(k) clearance for its C3 and L7 Clarius wireless ultrasound scanners. Clarius’ C3 multipurpose ultrasound scanner is designed...
View ArticleClik here to view.
GI Dynamics raises $1.1m in private placement
GI Dynamics (ASX:GID) said today it raised approximately $1.1 million (AU $1.5 million) and announced an upcoming security purchase plan looking to raise an additional $732,006 (AU $987,910). The...
View ArticleClik here to view.
Fresenius inks 5-year distro deal with Terumo to launch CATSmart in US
Fresenius (NYSE:FMS) business group Fresenius Kabi said today it inked a 5-year exclusive distribution deal with Terumo Corp. (TYO:4543) to launch Fresenius’ CATSmart autotransfusion system in the US....
View ArticleClik here to view.
J&J’s LifeScan wins FDA clearance for WellDoc integration of blood glucose data
Johnson & Johnson (NYSE:JNJ) subsidiary LifeScan said today it won FDA clearance for wireless integration of its OneTouch Verio Flex blood glucose monitoring system with WellDoc‘s FDA-approved...
View ArticleClik here to view.
Key elements of a viable post-market surveillance system
By Stewart Eisenhart, Emergo Group Although premarket registration and quality management system compliance garner a lot of attention from medical device companies eager to establish themselves in...
View ArticleClik here to view.
Hologic deals stake in Procleix blood-screening biz to Grifols for $1.9B
Hologic (NSDQ:HOLX) said yesterday that it agreed to deal its stake in the Procleix blood-screening business it runs with Grifols (NSDQ:GRFS) for nearly $1.9 billion. Hologic, which makes the Procleix...
View ArticleClik here to view.
FDA clears St. Jude Medical’s EnSite Precision heart map, Advisor FL catheter
St. Jude Medical (NYSE:STJ) said today that it won 510(k) clearance from the FDA for its EnSite Precision cardiac mapping system and the Advisor FL catheter used with it. The Ensite cardiac mapping...
View ArticleClik here to view.
Galderma wins FDA nod for dermal fillers
Galderma said today that it won FDA approval for 2 of its products to treat nasolabial folds, or “laugh lines”. The Fort Worth, Texas-based company’s Restylane Refyne and Restylane Defyne are made...
View ArticleClik here to view.
TiGenix IPO raises $36m
TiGenix (EBR:TIG) said today that it raised $36 million in an initial public offering from the sale of 2.3 million American depository shares, representing 46 million ordinary shares, at $15.50...
View ArticleClik here to view.
BD launches high volume syringe for biologics
Becton Dickinson (NYSE:BDX) said today that it launched its BD Neopak 2.25 milliliter prefillable glass syringe designed for high-volume injection of biologics. The Franklin Lakes, N.J.-based company...
View ArticleClik here to view.
Baxter to put up $625m for Claris Injectables generics biz
Baxter (NYSE:BAX) said today that acquired Claris Lifesciences (BOM:533288) subsidiary Claris Injectables for $625 million. The deal is expected to close in the 2nd half of next year. Deerfield,...
View ArticleClik here to view.
Ex pharma execs first to be charged in generic drug pricing case
Former Heritage Pharmaceuticals CEO Jeffrey Glazer and ex-president Jason Malek were hit yesterday with the 1st criminal charges from a 2-year federal investigation in an ongoing generic drug pricing...
View ArticleClik here to view.
Best of 2016: Top 10 regulatory stories
In a year of huge product debuts from major medical device players, a dark horse was the most-read regulatory story of 2016: Obalon Therapeutics and the weight-loss device it developed won that title...
View Article
